06.13.16
Galderma is celebrating the 20th global anniversary of its Restylane portfolio of products, with an updated package design that includes an updated syringe delivery system.
Restylane is one of the world's most studied wrinkle fillers, Galderma states. The skin care line is used in more than 65 countries worldwide, with over 28 million treatments administered globally, to date, according to the company.
The complete line of Restylane fillers includes Restylane, Restylane-L, Restylane Lyft with Lidocaine and Restylane Silk – and represent more than 20 years of research. Healthcare professionals customize a tretment plan for thier patients.
Updating a Delivery System
Galderma is also introducing a new, enhanced syringe for Restylane and Restylane Lyft, and the new packaging will be available to practitioners now, in time for the second half of 2016.
The syringe's new design is focused on providing a greater working comfort and enhanced ergonomics for the injector, as well as sturdy construction and upgraded safety measures. It also features a tamper-proof seal for a higher level of anti-counterfeiting protection and safety, for both patients and clinicians.
Designed for Ease of Use
In addition to functionality, the new design also features new aesthetics. Updated graphics give the brand a new look that is designed to simplify product identification and selection.
Kelly Huang, PhD, Vice President and General Manager, Aesthetic & Corrective Business Unit, Galderma, U.S. said, "All of us at Galderma are inspired by this significant milestone for Restylane. The combination of the proven safety history backed by over 28 million treatments globally and a continual pipeline of innovation, such as our enhanced syringe introduction for key Restylane products, is a strong foundation for the Restylane brands to continue to support the goals of healthcare professionals and patients now and in the future."
Restylane is one of the world's most studied wrinkle fillers, Galderma states. The skin care line is used in more than 65 countries worldwide, with over 28 million treatments administered globally, to date, according to the company.
The complete line of Restylane fillers includes Restylane, Restylane-L, Restylane Lyft with Lidocaine and Restylane Silk – and represent more than 20 years of research. Healthcare professionals customize a tretment plan for thier patients.
Updating a Delivery System
Galderma is also introducing a new, enhanced syringe for Restylane and Restylane Lyft, and the new packaging will be available to practitioners now, in time for the second half of 2016.
The syringe's new design is focused on providing a greater working comfort and enhanced ergonomics for the injector, as well as sturdy construction and upgraded safety measures. It also features a tamper-proof seal for a higher level of anti-counterfeiting protection and safety, for both patients and clinicians.
Designed for Ease of Use
In addition to functionality, the new design also features new aesthetics. Updated graphics give the brand a new look that is designed to simplify product identification and selection.
Kelly Huang, PhD, Vice President and General Manager, Aesthetic & Corrective Business Unit, Galderma, U.S. said, "All of us at Galderma are inspired by this significant milestone for Restylane. The combination of the proven safety history backed by over 28 million treatments globally and a continual pipeline of innovation, such as our enhanced syringe introduction for key Restylane products, is a strong foundation for the Restylane brands to continue to support the goals of healthcare professionals and patients now and in the future."
